Mealey's (August 5, 2020, 10:49 AM EDT) -- ABINGDON, Va. — Drug maker Indivior PLC and related entities on July 24 pleaded guilty to making false statements relating to its Suboxone opioid treatment drug and entered into three agreements to resolve criminal and civil allegations for $600 million in criminal and civil penalties (United States v. Indivior, Inc., et al., No. 19-cr-16, Federal Trade Commission v. Indivior Inc., No. 20-36, W.D. Va., Abington Div.)....